Abstract
Aim:
To investigate the role of transcription factor c-Ets1 in cyclin D3 expression and its effects on the proliferation of umbilical cord hematopoietic cells.
Methods:
Cyclin D3 promoter deletion constructs were generated and transfected into CD34+ cells. Dual luciferase reporter assays and TFSEARCH software were used to identify negative regulatory domains and to predict putative transcription factors involved in cyclin D3 downregulation. Expression of c-Ets1 in CD34+ cells was detected using electrophoretic mobility shift and super shift assays. Point mutants of c-Ets1 binding sites were constructed. The wild-type c-Ets1 and the mutant promoter constructs were co-transfected into CD34+ cells to determine the promoter activity. The impact of c-Ets1 expression on the proliferation of CD34+ cells was assessed using MTT assay.
Results:
Nine cyclin D3 promoter deletion constructs were generated. A negative regulatory domain containing c-Ets1 binding sites was identified between −439 bp and −362 bp. Transfection of the promoter deletion constructs containing mutant c-Ets1 binding sites enhanced cyclin D3 promoter activity. However, the opposite results were observed when CD34+ cells were co-transfected with wildtype c-Ets1 and its promoter deletion constructs. The overexpression of c-Ets1 could suppress cyclin D3 mRNA and protein levels. In addition, it inhibits the proliferation of CD34+ cells.
Conclusion:
c-Ets1 functions as a negative transcription factor, down-regulating the expression of cyclin D3, which leads to inhibition of CD34+ cell proliferation.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Jude CD, Gaudet JJ, Speck NA, Ernst P . Leukemia and hematopoietic stem cells: balancing proliferation and quiescence. Cell Cycle 2008; 7: 586–91.
Della Ragione F, Borriello A, Mastropietro S, Della Pietra V, Monno F, Gabutti V, et al. Expression of G1-phase cell cycle genes during hematopoietic lineage. Biochem Biophys Res Commun 1997; 231: 73–6.
Ma Y, Yuan J, Huang M, Jove R, Cress WD . Regulation of the cyclin D3 promoter by E2F1. J Biol Chem 2003; 278: 16770–6.
Masamha CP, Benbrook DM . Cyclin D1 degradation is sufficient to induce G1 cell cycle arrest despite constitutive expression of cyclin E2 in ovarian cancer cells. Cancer Res 2009; 69: 6565–72.
Kozar K, Ciemerych MA, Rebel VI, Shigematsu H, Zagozdzon A, Sicinska E, et al. Mouse development and cell proliferation in the absence of D-cyclins. Cell 2004; 118: 477–91.
Ando K, Ajchenbaum-Cymbalista F, Griffin JD . Regulation of G1/S transition by cyclins D2 and D3 in hematopoietic cells. Proc Natl Acad Sci U S A 1993; 90: 9571–5.
Dittmer J . The biology of the Ets1 proto-oncogene. Mol Cancer 2003; 2: 29.
Eyquem S, Chemin K, Fasseu M, Chopin M, Sigaux F, Cumano A, et al. The development of early and mature B cells is impaired in mice deficient for the Ets-1 transcription factor. Eur J Immunol 2004; 34: 3187–96.
Jackers P, Szalai G, Moussa O, Watson DK . Ets-dependent regulation of target gene expression during megakaryopoiesis. J Biol Chem 2004; 279: 52183–90.
Marziali G, Perrotti E, Ilari R, Lulli V, Coccia EM, Mazzeo S . Role of Ets–1 in erythroid differentiation. Blood Cells Mol Dis 2002; 29: 553–61.
Lulli V, Romania P, Riccioni R, Boe A, Lo-Coco F, Testa U, et al. Transcriptional silencing of the ETS1 oncogene contributes to human granulocytic differentiation. Haematologica 2010; 95: 1633–41.
Lulli V, Romania P, Morsilli O, Gabbianelli M, Pagliuca A, Mazzeo S, et al. Overexpression of Ets-1 in human hematopoietic progenitor cells blocks erythroid and promotes megakaryocytic differentiation. Cell Death Differ 2006; 13: 1064–74.
Lee MW, Jang IK, Yoo KH, Sung KW, Koo HH . Stem and progenitor cells in human umbilical cord blood. Int J Hematol 2010; 92: 45–51.
Kast C, Wang M, Whiteway M . The ERK/MAPK pathway regulates the activity of the human tissue factor pathway inhibitor-2 promoter. J Biol Chem 2003; 278: 6787–94.
Makaula S, Adam T, Essop MF . Upstream stimulatory factor 1 transactivates the human gene promoter of the cardiac isoform of acetyl-CoA carboxylase. Arch Biochem Biophys 2006; 446: 91–100.
Kanda S, Shiroi A, Ouji Y, Birumachi J, Ueda S, Fukui H, et al. In vitro differentiation of hepatocyte-like cells from embryonic stem cells promoted by gene transfer of hepatocyte nuclear factor 3 beta. Hepatol Res 2003; 26: 225–31.
Nesbit CE, Tersak JM, Prochownik EV . MYC oncogenes and human neoplastic disease. Oncogene 1999; 18: 3004–16.
Hahm K, Ernst P, Lo K, Kim GS, Turck C, Smale ST . The lymphoid transcription factor LyF-1 is encoded by specific, alternatively spliced mRNAs derived from the Ikaros gene. Mol Cell Biol 1994; 14: 7111–23.
Acknowledgements
This work was supported by the National Natural Science Foundation of China (No 30070326).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Meng, Fk., Sun, Hy., Tan, Xy. et al. Negative regulation of cyclin D3 expression by trans-cription factor c-Ets1 in umbilical cord hematopoietic cells. Acta Pharmacol Sin 32, 1159–1164 (2011). https://doi.org/10.1038/aps.2011.41
Received:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/aps.2011.41
